Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Allelix develops antiinflammatory peptides

Jan. 29, 1997

COX-2 inhibitors reported by Merck Frosst

Jan. 28, 1997

Merck Frosst discovers orally active COX-2 inhibitors

Jan. 24, 1997

MMP inhibitors disclosed by Fuji Yakuhin

Jan. 24, 1997

Eisai discloses IL-1 inhibitors

Jan. 23, 1997

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

Novel antiinflammatory protein available for licensing

Jan. 22, 1997

AutoImmune updates clinical program for oral RA product

Jan. 17, 1997

Genelabs completes first pivotal trial on SLE Rx

Jan. 16, 1997

Chiroscience investigates MMP/TNF inhibitors

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Hits’ Hyperlab launches as ‘virtual AI lab’ for new drug discovery
BioWorld Science
Things once done in laboratories can now be done with computers and AI, said Kim Woo-youn, CEO and cofounder of Hits Inc. “We live in the age of ‘digital...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...